Type 2 Diabetes mellitus Flashcards

1
Q

What is type 2 diabetes?

A

A condition in which the combination of insulin resistance and beta-cell failure result in hyperglycaemia
Associated with obesity but not always

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is another term for type 2 diabetes?

A

Relative insulin deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does development of type 2 diabetes associate with age?

A

Can present in any decade of life
Increasing in all ages but rapidly in early-adulthood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Outline the epidemiology of type 2 diabetes

A

Prevalence varies across countries enormously
Increasing prevalence
Occurring and being diagnosed younger
Greatest in ethnic groups that move from rural to urban lifestyle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the stages of development of type 2 diabetes?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is type 2 diabetes diagnosed?

A

Random glucose >11.1 mmol/L + osmotic symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe beta-cell function at diagnosis of T2DM

A

Usually dropped quite low before diagnosis ~ 50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why doesn’t hyperglycaemia normally cause ketosis in T2DM?

A

Insulin is still being produced by beta cells and this is enough to prevent ketosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What may be observed in long-duration T2DM?

A

Beta-cell failure may progress to complete insulin deficiency
Usually on insulin at this point but important not to stop as at risk of ketoacidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What factors are involved in the pathophysiology of T2DM?

A

Genes, intrauterine environment and adult environment
Fatty acids are important in pathogenesis and complications
Insulin resistance and insulin secretion defects
Heterogenous - variable BMI, age and progression across individuals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What happens when an individual with T2DM is given an IV glucose challenge?

A

First phase insulin release is lost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does T2DM affect skeletal muscle and hepatic glucose production?

A

Less uptake of glucose into skeletal muscle
Hepatic glucose production is increased due to both a reduction in insulin action and increase in glucagon action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Aside from diet, what also contributes to high plasma glucose in T2DM?

A

Impaired glucose disposal (clearance) and increased hepatic glucose production (HGP) contribute to increased fasting plasma glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does insulin secretion differ in an individual with T2DM vs an individual without?

A

For a given degree of insulin sensitivity, people with T2DM secrete less insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the genetics of T2DM

A

Monogenic -> Single gene mutation ==> Diabetes (MODY)
Polygenic -> Polymorphisms increasing risk of diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Approximately how many hits were there in the GWAS for T2DM and how much did they affect risk?

A

Approximately 450 hits
Each individual SNP has only a mild effect on risk
However cumulative effect of all SNPs have a bigger effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the role of obesity in T2DM?

A

Major risk factor for T2DM
Fatty acids and adipocytokines important
Central vs visceral obesity
80% T2DM are obese
Weight reduction useful treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What other factors, aside from obesity, are associated with T2DM?

A

Perturbations in gut microbiota:
- Bacterial lipopolysaccharides fermentation to short chain FA
- Bacterial modulation of bile acids
- Inflammation
Intra-uterine growth retardation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How does T2DM present?

A

Hyperglycaemia
Overweight
Dyslipidaemia
Fewer osmotic symptoms
With complications
Insulin resistance
Later insulin deficiency

20
Q

What are the risk factors of T2DM?

A

Age
PCOS
Higher BMI
Family Hx
Ethnicity
Inactivity

21
Q

How is type 2 diabetes diagnosed?

A

First line test: HbA1c
1x HbA1c >/= 48 mmol/L with symptoms
Or
2x HbA1c >/= 48 mmol/L if asymptomatic

22
Q

What can lead to a type 2 diabetes diagnosis?

A

Osmotic symptoms
Infections
Screening test: incidental finding
At presentation of complication:
- Acute; hyperosmolar hyperglycaemic state
- Chronic; ischaemic heart disease, retinopathy

23
Q

What is hyperosmolar hyperglycaemic state?

A

Insufficient insulin for prevention of hyperglycemia but sufficient insulin for suppression of lipolysis and ketogenesis
Absence of significant acidosis
Often identifiable precipitating event (infection, MI)

24
Q

What does hyperosmolar hyperglycaemic state commonly present with?

A

Presents commonly with renal failure

25
What are the differences between DKA and hyperosmolar hypoglycaemic state?
26
Compare management of type 1 vs type 2 diabetes
Type 1: Exogenous insulin (basal-bolus regime) Self-monitoring of glucose Structured education Technology Type 2: Diet Oral medication Structured education May need insulin later Remission / reversal Both require prevention of diabetes-related complications and their risk factors
27
What are the principles of a T2DM consultation?
Glycaemia: HbA1c, glucose monitoring if on insulin, medication review Weight assessment Blood pressure Dyslipidaemia: cholesterol profile Screening for complications: foot check, retinal screening
28
What are some dietary recommendations for people with T2DM?
Healthy eating or diet: Total calories control Reduce calories as fat Reduce calories as refined carbohydrate Increase calories as complex carbohydrate Increase soluble fibre Decrease sodium
29
What drug deals with excess hepatic glucose production?
Metformin
30
What drug(s) deals with resistance to action of circulating insulin?
Metformin Thiozolidinediones
31
What drug(s) deal with inadequate insulin production required to combat insulin resistance?
Sulphonylureas DPP4-inhibitors GLP-1 Agonists Boost insulin secretion
32
What drug(s) deal with excess glucose in circulation?
Alpha glucosidase inhibitor SGLT-2 inhibitor
33
What is the first line medication if dietary/lifestyle adjustment has made no difference?
Metformin
34
What is the mechanism of action of Metformin?
Biguanide Insulin sensitiser Reduces insulin resistance by reducing hepatic glucose output and increasing peripheral glucose disposal
35
What are the side effects and contraindications of Metformin?
GI side effects Contraindicated in severe liver, severe cardiac or moderate renal failure
36
What is the mechanism of action of sulphonylureas?
Sulphonylureas eg gliclazide, bind to the ATP-sensitive potassium channel and close it, independent of glucose / ATP
37
What is Pioglitazone?
Peroxisome proliferator-activated receptor agonists PPAR-γ Insulin sensitizer, mainly peripheral
38
What is the mechanism of action of Pioglitazone?
Modifies adipocyte differentiation
39
What are the effects of Pioglitazone?
Improvement in glycaemia and lipids Evidence base on vascular outcomes May cause peripheral weight gain Side effects of older types hepatitis, heart failure
40
What is GLP-1?
Gut hormone Secreted in response to nutrients in gut Transcription product of pro-glucagon gene, mostly from L-cell
41
Why is GLP-1 used in the treatment of T2DM?
Stimulates insulin, suppresses glucagon ↑ satiety (feeling of ‘fullness’) - weight loss However, short half life due to rapid degradation from enzyme dipeptidyl peptidase-4 (DPP4 inhibitor)
42
What do DPPG-4 inhibitors (gliptins) do?
Increase half life of exogenous GLP-1 Increase [GLP-1] Decrease [glucagon] Decrease [glucose] Neutral on weight
43
What do SGLT-2 inhibitors do?
Inhibit Na-Glu transporter, increase glycosuria E.g. dapagliflozin, canagliflozin
44
What are the benefits of SGLT-2 inhibitors?
HbA1c lower 32% lower all cause mortality 35% lower risk heart failure Improve CKD
45
What treatments have the potential of T2DM remission?
Gastric bypass DIRECT/DROPLET study - very low calorie diet for 3-6 months has potential to induce remission
46
Does treatment stop beta-cell function decline?
No
47
What are the other aspects of T2DM management?
Blood Pressure management Lipid management